Immunohistochemical examination of novel rat monoclonal antibodies against mouse and human podoplanin

Acta Histochemica et Cytochemica

Volumn 45, Issue 4, 2012, Pages 227-237

  Kaji, Chiaki ^a   Tsujimoto, Yuta ^b   Kaneko, Mika Kato ^b   Kato, Yukinari ^b   Sawa, Yoshihiko ^a  

^a FUKUOKA DENTAL COLLEGE   (Japan)

^b YAMAGATA UNIVERSITY   (Japan)

Author keywords

Monoclonal antibody; NZ 1.2; PMab 1; Podoplanin

Indexed keywords

EID: 84867845305     PISSN: 00445991     EISSN: 13475800     Source Type: Journal    
DOI: 10.1267/ahc.12008     Document Type: Article

References (37)

1. Breiteneder-Geleff, S., Matsui, K., Soleiman, A., Meraner, P., Poczewski, H., Kalt, R., Schaffner, G. and Kerjaschki, D. (1997) Podoplanin, novel43-kd membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis. Am. J. Pathol. 151; 1141-1152.
2. Dobbs, L. G., Williams, M. C. and Gonzalez, R. (1988) Monoclonal antibodies specific to apical surfaces of rat alveolar type I cells bind to surfaces of cultured, but not freshly isolated, type II cells. Biochim. Biophys. Acta 970; 146-156.
3. Hantusch, B., Kalt, R., Krieger, S., Puri, C. and Kerjaschki, D. (2007) Sp1/Sp3 and DNA-methylation contribute to basal transcriptional activation of human podoplanin in MG63 versus Saos-2 osteoblastic cells. BMC Mol. Biol. 8; 20.
4. Hata, M., Ueki, T., Sato, A., Kojima, H. and Sawa, Y. (2008) Expression of podoplanin in the mouse salivary glands. Arch. Oral Biol. 53; 835-841.
5. Hata, M., Amano, I., Tsuruga, E., Kojima, H. and Sawa, Y. (2010) Immunoelectron microscopic study of podoplanin localization in mouse salivary gland myoepithelium. Acta Histochem. Cytochem. 43; 77-82.
6. Imaizumi, Y., Amano, I., Tsuruga, E., Kojima, H. and Sawa, Y. (2010) Immunohistochemical examination for the distribution of podoplanin-expressing cells in developing mouse molar tooth germs. Acta Histochem. Cytochem. 43; 115-121.
7. Kaneko, M., Kato, Y., Kunita, A., Fujita, N., Tsuruo, T. and Osawa, M. (2004) Functional sialylated O-glycan to platelet aggregation on Aggrus (T1alpha/Podoplanin) molecules expressed in Chinese hamster ovary cells. J. Biol. Chem. 279; 38838-38843.
8. Kaneko, M. K., Kato, Y., Kitano, T. and Osawa, M. (2006) Conservation of a platelet activating domain of Aggrus/podoplanin as a platelet aggregation-inducing factor. Gene 378; 52-57.
9. Kaneko, M. K., Kato, Y., Kameyama, A., Ito, H., Kuno, A., Hirabayashi, J., Kubota, T., Amano, K., Chiba, Y., Hasegawa, Y., Sasagawa, I., Mishima, K. and Narimatsu, H. (2007) Functional glycosylation of human podoplanin: glycan structure of platelet aggregation-inducing factor. FEBS Lett. 581; 331-336.
10. Kato, Y., Fujita, N., Kunita, A., Sato, S., Kaneko, M. and Osawa, M. (2003) Molecular identification of Aggrus/T1a as a platelet aggregation-inducing factor expressed in colorectal tumors. J. Biol. Chem. 278; 51599-51605.
11. Kato, Y., Kaneko, M. K., Kuno, A., Uchiyama, N., Amano, K., Chiba, Y., Hasegawa, Y., Hirabayashi, J., Narimatsu, H., Mishima, K. and Osawa, M. (2006) Inhibition of tumor cellinduced platelet aggregation using a novel anti-podoplanin antibody reacting with its platelet-aggregation-stimulating domain. Biochem. Biophys. Res. Commun. 349; 1301-1307.
12. Kato, Y., Kaneko, M. K., Kunita, A., Ito, H., Kameyama, A., Ogasawara, S., Matsuura, N., Hasegawa, Y., Suzuki-Inoue, K., Inoue, O., Ozaki, Y. and Narimatsu, H. (2008) Molecular analysis of the pathophysiological binding of the platelet aggregationinducing factor podoplanin to the C-type lectin-like receptor CLEC-2. Cancer Sci. 99; 54-61.
13. Kawaguchi, H., El-Naggar, A. K., Papadimitrakopoulou, V., Ren, H., Fan, Y. H., Feng, L., Lee, J. J., Kim, E., Hong, W. K., Lippman, S. M. and Mao, L. (2008) Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancy. J. Clin. Oncol. 26; 354-360.
14. Kimura, N. and Kimura, I. (2005) Podoplanin as a marker for mesothelioma. Pathol. Int. 55; 83-86.
15. Koop, K., Eikmans, M., Wehland, M., Baelde, H., Ijpelaar, D., Kreutz, R., Kawachi, H., Kerjaschki, D., de Heer, E. and Bruijn, J. A. (2008) Selective loss of podoplanin protein expression accompanies proteinuria and precedes alterations in podocyte morphology in a spontaneous proteinuric rat model. Am. J. Pathol. 173; 315-326.
16. Kunita, A., Kashima, T. G., Morishita, Y., Fukayama, M., Kato, Y., Tsuruo, T. and Fujita, N. (2007) The platelet aggregationinducing factor aggrus/podoplanin promotes pulmonary metastasis. Am. J. Pathol. 170; 1337-1347.
17. Marsee, D. K., Pinkus, G. S. and Hornick, J. L. (2009) Podoplanin (D2-40) is a highly effective marker of follicular dendritic cells. Appl. Immunohistochem. Mol. Morphol. 17; 102-107.
18. Martín-Villar, E., Scholl, F. G., Gamallo, C., Yurrita, M. M., Muñoz-Guerra, M., Cruces, J. and Quintanilla, M. (2005) Characterization of human PA2.26 antigen (T1alpha-2, podoplanin), a small membrane mucin induced in oral squamous cell carcinomas. Int. J. Cancer. 113; 899-910.
19. Nagato, T., Yoshida, H., Yoshida, A. and Uehara, Y. (1980) A scanning electron microscope study of myoepithelial cells in exocrine glands. Cell Tissue Res. 209; 1-10.
20. Noda, Y., Amano, I., Hata, M., Kojima, H. and Sawa, Y. (2010) Immunohistochemical examination of the distribution of cells expressed lymphatic endothelial marker podoplanin and LYVE-1 in the mouse tongue tissue. Acta Histochem. Cytochem. 43; 61-68.
21. Ogasawara, S., Kaneko, M. K., Price, J. E. and Kato, Y. (2008) Characterization of anti-podoplanin monoclonal antibodies: critical epitopes for neutralizing the interaction between podoplanin and CLEC-2. Hybridoma (Larchmt) 27; 259-267
22. Ramirez, M. I., Millien, G., Hinds, A., Cao, Y. X., Seldin, D. C. and Williams, M. C. (2003) T1alpha, a lung type I cell differentiation gene, is required for normal lung cell proliferation and alveolous formation at birth. Dev. Biol. 256; 61-72.
23. Rishi, A. K., Joyce-Brady, M., Fisher, J., Dobbs, L. G., Floros, J., VanderSpek, J., Brody, J. S. and Williams, M. C. (1995) Cloning, characterization, and development expression of a rat lung alveolar type I cell gene in embryonic endodermal and neural derivatives. Dev. Biol. 167; 294-306.
24. Sawa, Y., Tsuruga, E., Iwasawa, K., Ishikawa, H. and Yoshida, S. (2008) Leukocyte adhesion molecule and chemokine production through lipoteichoic acid recognition by toll-like receptor 2 in cultured human lymphatic endothelium. Cell Tissue Res. 333; 237-252.
25. Sawa, Y. and Tsuruga, E. (2008) The expression of E-selectin and chemokines in the cultured human lymphatic endothelium with lipopolysaccharides. J. Anat. 212; 654-663.
26. Sawa, Y., Ueki, T., Hata, M., Iwasawa, K., Tsuruga, E., Kojima, H., Ishikawa, H. and Yoshida, S. (2008) LPS-induced IL-6, IL-8, VCAM-1, and ICAM-1 expression in human lymphatic endothelium. J. Histochem. Cytochem. 56; 97-109.
27. Schacht, V., Ramirez, M. I., Hong, Y. K., Hirakawa, S., Feng, D., Harvey, N., Williams, M., Dvorak, A. M., Dvorak, H. F., Oliver, G. and Detmar, M. (2003) T1a/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema. EMBO J. 22; 3546-3556.
28. Schacht, V., Dadras, S. S., Johnson, L. A., Jackson, D. G., Hong, Y. K. and Detmar, M. (2005) Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. Am. J. Pathol. 166; 913-921.
29. Sugimoto, Y., Watanabe, M., Oh-hara, T., Sato, S., Isoe, T. and Tsuruo, T. (1991) Suppression of experimental lung colonization of a metastatic variant of murine colon adenocarcinoma 26 by a monoclonal antibody 8F11 inhibiting tumor cell-induced platelet aggregation. Cancer Res. 51; 921-925.
30. Suzuki-Inoue, K., Kato, Y., Inoue, O., Kaneko, M. K., Mishima, K., Yatomi, Y., Yamazaki, Y., Narimatsu, H. and Ozaki, Y. (2007) Involvement of the snake toxin receptor CLEC-2, in podoplaninmediated platelet activation, by cancer cells. J. Biol. Chem. 282; 25993-26001.
31. Watanabe, M., Okochi, E., Sugimoto, Y. and Tsuruo, T. (1988) Identification of a platelet-aggregating factor of murine colon adenocarcinoma 26: Mr 44,000 membrane protein as determined by monoclonal antibodies. Cancer Res. 48; 6411-6416.
32. Watanabe, M., Sugimoto, Y. and Tsuruo, T. (1990) Expression of a Mr 41,000 glycoprotein associated with thrombin-independent platelet aggregation in high metastatic variants of murine B16 melanoma. Cancer Res. 50; 6657-6662.
33. Wetterwald, A., Hoffstetter, W., Cecchini, M. G., Lanske, B., Wagner, C., Fleisch, H. and Atkinson, M. (1996) Characterization and cloning of the E11 antigen, a marker expressed by rat osteoblasts and osteocytes. Bone 18; 125-132.
34. Wicki, A., Lehembre, F., Wick, N., Hantusch, B., Kerjaschki, D. and Christofori, G. (2006) Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton. Cancer Cell 9; 261-272.
35. Williams, M. C., Cao, Y., Hinds, A., Rishi, A. K. and Wetterwald, A. (1996) T1alpha protein is developmentally regulated and expressed by alveolar type I cells, choroid plexus and ciliary epithelia of adult rats. Am. J. Respir. Cell Mol. Biol. 14; 577-585.
36. Yu, H., Gibson, J. A., Pinkus, G. S. and Hornick, J. L. (2007) Podoplanin (D2-40) is a novel marker for follicular dendritic cell tumors. Am. J. Clin. Pathol. 128; 776-782.
37. Yuan, P., Temam, S., El-Naggar, A., Zhou, X., Liu, D. D., Lee, J. J. and Mao, L. (2006) Overexpression of podoplanin in oral cancer and its association with poor clinical outcome. Cancer 107; 563-569.